Effect of recombinant human growth hormone on blood sugar of patients with severe burn
10.3760/cma.j.issn.1001-8050.2010.08.027
- VernacularTitle:生长激素对不同年龄重度烧伤患者的血糖影响
- Author:
Guoliang SU
;
Jiong CHEN
;
Jianwu SHI
;
Shichun XIA
;
Bing XIE
- Publication Type:Journal Article
- Keywords:
Recombinant human growth hormone;
Blood sugar;
Burn
- From:
Chinese Journal of Trauma
2010;26(8):749-751
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the changes of blood sugar following use of recombinant human growth hormone (rhGH) in patients with severe burn. Methods A total of 140 patients with severe burn but with no history of diabetes were randomly and equally divided into Group A ( 18-44 years old) and Group B ( ≥45 years old) according to WHO criteria. Then, two groups were randomly divided Group B0 (treated with normal saline), 35 patients per group. Change of blood sugar and amount of insuline for control of blood sugar were observed and analyzed. Results Of 140 patients in four groups,128 patients accomplished the test, with no statistical difference upon general conditions between groups (P ＞0.05 ). Within four weeks after test, the amount of insuline used for control of blood sugar was (2908.0 ± 153.5) IU and (724.1 ± 31.1 ) IU respectively in Groups A1 and A0, (3725.9 ± 88.4) IU and (801.8 ±22.2) IU respectively in Groups B1 and BO. The results showed that the patients needing insulin to control blood sugar in Group B were more than that in Group A ( P ＜ 0.01 ). The time for blood sugar recovering to normal range in patients with high blood sugar with no use of rhGH in Group A1 and Group B1 was (5.21 ±0.64) d and (5.03 ± 1.01) d respectively (P＞0.05). Conclusions The blood sugar of patients with severe burn will rise after use of rhGH. The age of the patients is positively correlated with changes of blood sugar. Standard use of rhGH does not induce diabetes.
